GB2216416B - Nucleobase source for the stimulation of the immune system - Google Patents

Nucleobase source for the stimulation of the immune system

Info

Publication number
GB2216416B
GB2216416B GB8905179A GB8905179A GB2216416B GB 2216416 B GB2216416 B GB 2216416B GB 8905179 A GB8905179 A GB 8905179A GB 8905179 A GB8905179 A GB 8905179A GB 2216416 B GB2216416 B GB 2216416B
Authority
GB
United Kingdom
Prior art keywords
stimulation
immune system
nucleobase source
nucleobase
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8905179A
Other versions
GB2216416A (en
GB8905179D0 (en
Inventor
Frederick B Rudolph
Buren Charles T Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8905179D0 publication Critical patent/GB8905179D0/en
Publication of GB2216416A publication Critical patent/GB2216416A/en
Application granted granted Critical
Publication of GB2216416B publication Critical patent/GB2216416B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
GB8905179A 1988-03-11 1989-03-07 Nucleobase source for the stimulation of the immune system Expired - Lifetime GB2216416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16686688A 1988-03-11 1988-03-11

Publications (3)

Publication Number Publication Date
GB8905179D0 GB8905179D0 (en) 1989-04-19
GB2216416A GB2216416A (en) 1989-10-11
GB2216416B true GB2216416B (en) 1992-06-24

Family

ID=22604997

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8905179A Expired - Lifetime GB2216416B (en) 1988-03-11 1989-03-07 Nucleobase source for the stimulation of the immune system

Country Status (9)

Country Link
JP (1) JPH01279835A (en)
BE (1) BE1002937A5 (en)
CH (1) CH681203A5 (en)
DE (1) DE3907842A1 (en)
FR (1) FR2628320A1 (en)
GB (1) GB2216416B (en)
IT (1) IT1232819B (en)
NL (1) NL8900581A (en)
SE (1) SE8900835L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2529605B2 (en) * 1989-10-23 1996-08-28 株式会社大塚製薬工場 Immunostimulant
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6706691B1 (en) 1998-07-15 2004-03-16 Board Of Regents, The University Of Texas System Immunosupportive drug sparing diet
ES2219182B1 (en) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez PROCEDURE TO COMPENSATE THE NEGATIVE EFFECT ON HEALTH OF FOODS THAT CONTAIN REFINED SUGAR.

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS385291B1 (en) * 1960-09-07 1963-05-07
GB971999A (en) * 1960-12-29 1964-10-07 Takeda Chemical Industries Ltd Improvements in or relating to food preparations containing nucleotides
GB1187830A (en) * 1966-12-23 1970-04-15 Merck & Co Inc Pharmaceutical Compositions comprising Polynucleotides
GB1229888A (en) * 1967-06-19 1971-04-28
GB1254744A (en) * 1969-06-19 1971-11-24 Beecham Group Ltd Antiviral ribonucleic acid substance
GB1270049A (en) * 1969-08-18 1972-04-12 Bengt Sylven New pharmaceutical product
GB1363398A (en) * 1973-03-29 1974-08-14 Yamasa Shoyu Kk Uridine-5.-monophosphate compositions
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
GB1546322A (en) * 1976-06-03 1979-05-23 Beljanski M Polyribonucleotides apable of promoting the genesis of leucocytes and blood platelets
GB1551178A (en) * 1976-12-21 1979-08-22 Fabre Sa Pierre Nonspecific immunity adjuvants
EP0031285A2 (en) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Immuno-stimulating preparations based on ribosomal RNA of Klebsiella pneumoniae and process for the preparation of these RNA
EP0112632A2 (en) * 1982-11-09 1984-07-04 Scripps Clinic And Research Foundation Use of 8-substituted guanine derivatives in the manufacture of a medicament.
GB2140689A (en) * 1983-05-30 1984-12-05 Mitsui Toatsu Chemicals Treating digestive ulcers using dna
JPS608307A (en) * 1983-06-28 1985-01-17 Ube Ind Ltd Production of reinforced polybutadiene
GB2152814A (en) * 1983-12-09 1985-08-14 Otsuka Pharma Co Ltd Nucleic acid compositions
EP0196530A2 (en) * 1985-03-26 1986-10-08 CTA Finanz AG Agent and process for increasing growth, for optimizing fertility and for stimulating the immune system in humans and animals
EP0216133A1 (en) * 1985-08-16 1987-04-01 Nissan Chemical Industries Ltd. Nutritional agent for the cerebrospinal nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT945910B (en) * 1971-04-08 1973-05-10 Erra C Spa DIET PRODUCT THAT CAN BE USED AS AN INTERGRATOR OF HUMAN FOOD WITH PARTICULAR REFERENCE TO CHILDHOOD, CONVALESCENCE OF PREGNANCY FROM LACTATION AND BREAST AGE AND PROCEDURES FOR ITS MANUFACTURING
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS385291B1 (en) * 1960-09-07 1963-05-07
GB971999A (en) * 1960-12-29 1964-10-07 Takeda Chemical Industries Ltd Improvements in or relating to food preparations containing nucleotides
GB1187830A (en) * 1966-12-23 1970-04-15 Merck & Co Inc Pharmaceutical Compositions comprising Polynucleotides
GB1229888A (en) * 1967-06-19 1971-04-28
GB1254744A (en) * 1969-06-19 1971-11-24 Beecham Group Ltd Antiviral ribonucleic acid substance
GB1270049A (en) * 1969-08-18 1972-04-12 Bengt Sylven New pharmaceutical product
GB1363398A (en) * 1973-03-29 1974-08-14 Yamasa Shoyu Kk Uridine-5.-monophosphate compositions
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
GB1546322A (en) * 1976-06-03 1979-05-23 Beljanski M Polyribonucleotides apable of promoting the genesis of leucocytes and blood platelets
GB1551178A (en) * 1976-12-21 1979-08-22 Fabre Sa Pierre Nonspecific immunity adjuvants
EP0031285A2 (en) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Immuno-stimulating preparations based on ribosomal RNA of Klebsiella pneumoniae and process for the preparation of these RNA
EP0112632A2 (en) * 1982-11-09 1984-07-04 Scripps Clinic And Research Foundation Use of 8-substituted guanine derivatives in the manufacture of a medicament.
GB2140689A (en) * 1983-05-30 1984-12-05 Mitsui Toatsu Chemicals Treating digestive ulcers using dna
JPS608307A (en) * 1983-06-28 1985-01-17 Ube Ind Ltd Production of reinforced polybutadiene
GB2152814A (en) * 1983-12-09 1985-08-14 Otsuka Pharma Co Ltd Nucleic acid compositions
EP0196530A2 (en) * 1985-03-26 1986-10-08 CTA Finanz AG Agent and process for increasing growth, for optimizing fertility and for stimulating the immune system in humans and animals
EP0216133A1 (en) * 1985-08-16 1987-04-01 Nissan Chemical Industries Ltd. Nutritional agent for the cerebrospinal nervous system

Also Published As

Publication number Publication date
NL8900581A (en) 1989-10-02
FR2628320A1 (en) 1989-09-15
IT8947733A0 (en) 1989-03-10
BE1002937A5 (en) 1991-09-03
SE8900835D0 (en) 1989-03-09
GB2216416A (en) 1989-10-11
JPH01279835A (en) 1989-11-10
DE3907842A1 (en) 1989-09-21
CH681203A5 (en) 1993-02-15
GB8905179D0 (en) 1989-04-19
IT1232819B (en) 1992-03-05
SE8900835L (en) 1989-09-12

Similar Documents

Publication Publication Date Title
YU67987A (en) Flat therapeutic system
IL87453A0 (en) Starting/generating system
GB8706152D0 (en) Patient support system for radiotherapy
GB8717643D0 (en) Oral therapeutic system
EP0292269A3 (en) Integrated high voltage generating system
CY1833A (en) Therapeutic nucleosides
AP8800086A0 (en) Therapeutic nucleosides
AU2221688A (en) Method for stimulating the immune system
ZA896450B (en) Viral treatment system
GB8706153D0 (en) Patient support system for radiotherapy
GB2216416B (en) Nucleobase source for the stimulation of the immune system
GB8708579D0 (en) Control system for surface seismic source
EP0287215A3 (en) Therapeutic nucleosides
GB8706176D0 (en) Therapeutic nucleosides
GB8701878D0 (en) Alternative source system
EP0409894A4 (en) Platinum-amine-sulfoxides as anti-tumor agents
GB8712691D0 (en) Therapeutic nucleosides
GB8725250D0 (en) Seismic source
GB8725599D0 (en) Heat source
EP0412938A3 (en) System for the treatment of contactlenses
GB8725251D0 (en) Seismic source
IL87933A0 (en) Compositions for stimulating the immune system
GB8425783D0 (en) Treatment for immune system
GB8823689D0 (en) Medicament for enhancing immune system
GB8721650D0 (en) Controllable expression system

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960307